Sophia Genetics
Latest round
- Series F
Last raised
- Oct 2020
Total raised
- $231M
Investors
- 16
About Sophia Genetics
Based in Saint Sulpice, Switzerland, and founded in 2011, Sophia Genetics SA operates as a healthcare technology company that provides an analytic software platform for patients with oncology and rare diseases. The company has 415 employees as of July 2021 and was co-founded by Jurgi Camblong, Pierre Hutter, and Lars Steinmetz. Sophia Genetics develops a cloud-based Software-as-a-Service Sophia DDM platform that uses machine learning, statistical inference, and pattern recognition to collect more accurate radiomic data, characterize genomic variants, and connect patients to appropriate clinical trials. The company's technology is used to treat diseases, including cancer and hereditary disorders, where merging genomic and phenotypic data is critical for supporting discoveries, treatment decisions, and medication development.4 million in 2019.S. and Asian markets.
Who invested in Sophia Genetics
16 investors across 4 rounds
See all investors in Sophia Genetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sophia Genetics
Who invested in Sophia Genetics?
Sophia Genetics has 16 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sophia Genetics raised?
Sophia Genetics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Sophia Genetics last raise money?
Sophia Genetics's most recent round on record is a Series F, in Oct 2020.
What does Sophia Genetics do?
Based in Saint Sulpice, Switzerland, and founded in 2011, Sophia Genetics SA operates as a healthcare technology company that provides an analytic software platform for patients with oncology and rare diseases.
Where is Sophia Genetics headquartered?
Sophia Genetics is headquartered in Switzerland.
Which VCs invest in companies like Sophia Genetics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back healthcare it companies at Sophia Genetics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series F
Raising like Sophia Genetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.